The current clinical practice of pharmacogenetic testing in Europe: TPMT and HER2 as case studies

This publication has 13 references indexed in Scilit:

• Towards quality assurance and harmonization of genetic testing services in the European Union
  Nature Biotechnology, 2004
• Improved HPLC methodology for monitoring thiopurine metabolites in patients on thiopurine therapy
  Clinical Biochemistry, 2004
• Pharmacogenomics: bench to bedside
  Nature Reviews Drug Discovery, 2004
• HER-2 Testing and Trastuzumab Therapy for Metastatic Breast Cancer: A Cost-Effectiveness Analysis
  Journal of Clinical Oncology, 2004
• Pharmacogenetics: potential for individualized drug therapy through genetics
  Trends in Genetics, 2003
• Preventing Toxicity With a Gene Test
  2003
• Progress in systemic therapy for breast cancer: an overview and perspectives
  European Journal of Cancer Supplements, 2003
• Education: Teaching pharmacogenomics to prepare future physicians and researchers for personalized medicine
  Trends in Pharmacological Sciences, 2003
• Pharmacogenomics: out of the lab and into the community
  Trends in Biotechnology, 2001
• Assessing the cost-effectiveness of pharmacogenomics
  AAPS PharmSci, 2000